Doctors Ignore Top Insomnia Fix

Person lying awake in bed beside a glowing digital alarm clock — Photo: Tero Vesalainen / Shutterstock

Millions of Americans lie awake each night reaching for a pill when the treatment doctors actually rank as best barely gets a mention in the exam room.

Quick Take

Major medical guidelines name Cognitive Behavioral Therapy for Insomnia, known as CBT-I, as the first treatment doctors should offer for chronic insomnia.
The American College of Physicians and European sleep experts both say CBT-I should come before sleep medication for adults of any age.
Sleep drugs are meant to be a backup, not the starting point, according to the American Academy of Sleep Medicine.
Despite this advice, most patients still end up on medication because trained CBT-I therapists are hard to find.

What The Guidelines Actually Say

The American College of Physicians issued a clinical guideline in 2016 stating that doctors should use CBT-I “as the initial treatment for chronic insomnia disorder”. The European Insomnia Guideline updated in 2023 goes further, saying CBT-I “should be provided as the first-line treatment for insomnia disorder in adults of any age, regardless of comorbidities”. These are not fringe opinions. They come from the two most influential bodies shaping sleep medicine on either side of the Atlantic.

The American Academy of Sleep Medicine backs the same order of operations. Its guidance describes CBT-I as carrying a “significantly favorable benefit to risk ratio” compared to drugs. Medication, the group says, should mainly enter the picture when a patient cannot do CBT-I, does not respond to it, or needs short-term help while starting therapy. In plain terms: therapy first, pills as a fallback.

The Australasian Sleep Association calls CBT-I “universally accepted as the best treatment modality for insomnia disorder, in the long term,” adding it “remains the gold standard of treatment”. The American Academy of Family Physicians echoes this, noting CBT-I improves not just sleep quality but daytime fatigue, total sleep time, and even how patients think about sleep itself. That breadth of benefit is why guideline writers keep landing on the same answer.

Why So Many People Still Take A Pill Instead

If CBT-I works this well, a fair question follows: why do pharmacies fill so many sleep prescriptions? The answer is access, not evidence. Research shows trained CBT-I providers are scarce and unevenly spread across the country, leaving primary care doctors to reach for a prescription pad instead of a referral. One sleep journal bluntly called CBT-I “massively underused relative to the prevalence of insomnia disorder”.

Doctors themselves report gaps in training. Studies point to limited provider knowledge, treatment bias, and confusion about how to refer patients as recurring reasons CBT-I gets skipped. Patients face their own barriers too, including a lack of public awareness that behavioral therapy is even an option, plus the stigma some attach to therapy in general. The result is a system where the guideline-preferred treatment is often the hardest one to actually get.

The Medication Landscape Patients Actually Encounter

Prescribing data shows trazodone and zolpidem remain the most commonly prescribed sleep medications, far outpacing newer options like eszopiclone or ramelteon. A large network analysis found several common sleep drugs, including zolpidem, zopiclone, and eszopiclone, carry higher rates of side effects such as dizziness, headache, and next-day grogginess. None of this means the drugs are useless. It means they carry tradeoffs that guideline authors weighed before ranking behavioral therapy first.

One encouraging development is digital CBT-I. Research shows online and telehealth versions of the therapy perform comparably to in-person sessions, while cutting cost and wait times. For a country full of readers who cannot easily find a behavioral sleep specialist, that matters. It suggests the access problem, while real, is not permanent.

What This Means For Anyone Losing Sleep Tonight

The clinical consensus is not ambiguous. Ask a primary care doctor for CBT-I before accepting a prescription as the default plan. Insist on a referral, or look into a reputable digital CBT-I program if a local specialist is not available. Medication has a legitimate role for short-term relief or when therapy alone is not enough, but guidelines are clear that it should not be the first move.

Chronic insomnia is common, exhausting, and treatable. The frustrating part is not a lack of proven answers. It is a healthcare system still catching up to what its own guidelines have said for years.